TwoStep Therapeutics
CA - San CarlosBiotechnology
Focus: TwoStep Therapeutics is a pre-revenue biotech company focused on PIP (phosphoinositide 3-kinase inhibitor) therapies for oncology. The company is early-stage with minimal public commercial presence.
Profile data last refreshed 42m ago · AI intelligence enriched 2w ago
Open Jobs
4
Should You Work at TwoStep Therapeutics?
AI assessmentTwoStep is a speculative early-stage bet suitable only for risk-tolerant scientists/operators seeking equity upside and foundational role-building in a focused oncology platform.
Why Work Here
- Specialized focus on PIP therapies in oncology offers deep technical expertise in a validated mechanism class
- Small team structure (4 active roles) suggests hands-on involvement and rapid decision-making opportunities
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for TwoStep Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.